Piermont Capital Management Inc. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 166 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.89 and the average weighting 0.5%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2017$532,000
-16.7%
85,500
-15.2%
0.15%0.0%
Q1 2017$639,000
+10.9%
100,770
+109.9%
0.15%
-12.6%
Q2 2015$576,00048,0200.17%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2015
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders